Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX

Core Viewpoint - Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) [1] Company Summary - The investigation pertains to the actions of the directors and officers of Amylyx Pharmaceuticals, indicating possible misconduct or failure to act in the best interests of shareholders [1] - Shareholders of Amylyx Pharmaceuticals are encouraged to seek more information regarding the investigation through the law firm's website or by contacting them directly [1]